Description
Application for trading of 24,42,000 equity shares issued on preferential basis at Rs. 42.25 per share, with allotment dates on October 1st and 3rd, 2025.
Summary
Shelter Pharma Limited has applied to BSE for trading approval of 24,42,000 equity shares of face value Rs. 10 per share, issued on a preferential basis at Rs. 42.25 per share (including premium of Rs. 32.25). The allotment was completed in two tranches on October 1st and October 3rd, 2025, with distinctive numbers ranging from 1,15,59,793 to 1,40,01,792.
Key Points
- Total equity shares issued: 24,42,000
- Face value: Rs. 10 per share
- Issue price: Rs. 42.25 per share (premium: Rs. 32.25)
- Allotment dates: October 1, 2025 and October 3, 2025
- Lock-in periods: June 29-30, 2026 and June 30, 2027
- Distinctive number range: 1,15,59,793 to 1,40,01,792
- Managing Director: Mustaqim Nisarahmed Sabugar (DIN: 01456841)
Regulatory Changes
No regulatory changes introduced. This is a standard preferential allotment listing application.
Compliance Requirements
- Shares subject to lock-in until specified dates (June 2026 and June 2027)
- List of allottees provided as per BSE requirements
- Distinctive numbers assigned to track allotted shares
Important Dates
- Allotment Date 1: October 1, 2025
- Allotment Date 2: October 3, 2025
- Lock-in expiry dates: June 29-30, 2026 (for most allottees); June 30, 2027 (for remaining allottees)
- Circular date: December 23, 2025
Impact Assessment
Limited market impact as this is a company-specific preferential allotment. The lock-in periods ensure allottees cannot immediately sell shares, providing stability. The preferential issue increases Shelter Pharma’s equity base and provides capital infusion to the company. No immediate trading impact expected for broader market participants.
Impact Justification
Routine preferential allotment listing for a single company with standard lock-in periods; limited market-wide impact